Long-term gender disparities in new-onset heart failure after acute coronary syndrome

Pierluigi Merella1,2, Giuseppe Talanas1,2, Mehriban İsgender3,4

  • 1Clinical and Experimental Cardiology, Clinical and Interventional Cardiology, University of Sassari, Sassari, Italy.

ESC Heart Failure
|August 6, 2024
PubMed

Insights

Men with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI) face higher long-term risks of developing heart failure (HF) and mortality compared to women. Ischemic outcomes were similar between sexes.

Area of Science:

  • Cardiology
  • Clinical Outcomes
  • Sex Differences in Medicine

Background:

  • Limited research exists on long-term sex-specific outcomes after acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI).
  • The differential impact of heart failure (HF) on long-term prognosis in ACS patients remains unclear.

Purpose of the Study:

  • To investigate sex-related differences in long-term clinical outcomes following ACS treated with PCI.
  • To determine if heart failure (HF) has a differential impact on long-term prognosis in male versus female ACS patients.

Main Methods:

  • Analysis of a large-scale ACS patient database undergoing PCI.
  • Primary endpoint: new-onset HF. Secondary endpoints: mortality, myocardial infarction, re-PCI, ischemic stroke.
  • Propensity score matching used to balance groups; 5-year follow-up assessed.

Main Results:

  • At 5-year follow-up, males had a significantly higher risk of new-onset HF (17.9% vs. 14.8%) and mortality (HR 1.23) compared to females.
  • Mortality differences emerged after the first year and persisted.
  • Ischemic outcomes were comparable between male and female cohorts.

Conclusions:

  • Males exhibit a greater long-term risk of new-onset HF and higher mortality post-ACS and PCI compared to females.
  • New-onset HF is a key driver of long-term gender disparities and a predictor of mortality in men.
  • No significant differences in ischemic outcomes were observed between sexes.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
Panic Disorder01:27

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
56